Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women. (Q51325614)

3 April 2018

title

Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women. (English)

1 reference

3 April 2018

0 references

1 reference

Sahar Kamal Hegazy

1

1 reference

3 April 2018

publication date

15 March 2014

1 reference

3 April 2018

Journal of Bone and Mineral Metabolism

published in

1 reference

3 April 2018

volume

33

1 reference

3 April 2018

issue

2

1 reference

3 April 2018

page(s)

207-212

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s00774-014-0581-y

exact match

0 references

cites work

Diabetes Mellitus: Does it Affect Bone?

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Osteoporosis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Diabetes mellitus a risk for osteoporosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Oral antihyperglycemic therapy for type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Metformin reverses the deleterious effects of high glucose on osteoblast function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

AICAR, a small chemical molecule, primes osteogenic differentiation of adult mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Osteoblast differentiation is functionally associated with decreased AMP kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Incretin-based therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Incretin based therapies: bone protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-014-0581-Y

[Diabetes mellitus and osteoporosis. Effect of antidiabetic medicine on osteoporotic fracture]

21 January 2018

1 reference

12 December 2020

Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women

1 reference

12 December 2020

[Diabetes mellitus and osteoporosis. Incretin as a coordinator of glucose and bone metabolism]

1 reference

12 December 2020

Hemoglobin components in patients with diabetes mellitus

1 reference

12 December 2020

Clinical utility of biochemical markers of bone remodeling

1 reference

12 December 2020

Biochemical markers of bone turnover and response of bone mineral density to intervention in early postmenopausal women: an experience in a clinical laboratory

1 reference

12 December 2020

Pleiotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patients

1 reference

12 December 2020

Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metformin

1 reference

12 December 2020

10.1007/S00774-014-0581-Y

Identifiers

DOI

1 reference

3 April 2018

PubMed ID

24633493

1 reference

3 April 2018